Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
tba at Cytovance Biologics
Frank has over 16 years of experience in academia and industry. He is currently the Director of Microbial Bioprocess at Cytovance Biologics and he has been with the company since May 2014. Prior to Cytovance, Frank was a Scientist at Novozymes, ICM, Inc., and Mascoma Corporation. He also served as Application Technology Manager at Mascoma Corporation where he contributed to the FDA approval and launch of two commercial products (TransFerm®). His background includes microbial process development, Design of experiments, Process Optimization, Process Characterization and Scale-Up from R&D to Manufacturing (cGMP and non-cGMP). Frank oversees the Microbial Bioprocess development group at Cytovance Biologics and has been responsible for transferring processes from clients to R&D and to cGMP manufacturing. He was a presenter and Co-Chair at scientific conferences such as Society for Industrial Microbiology and Biotechnology (SIMB) and Recent Advances in Fermentation Technology (RAFT). He is an author of 15 peer-reviewed papers and holds 5 patents. Frank has expertise with multiple microbial host strains including E. coli, P. Pastoris, C. thermocellum, S. cerevisiae, and P. stipitis. Frank holds a B.S. in Chemical Engineering from Kwame Nkrumah University of Science and Technology in Kumasi, Ghana, and a Ph.D. in Chemical Engineering from Texas A&M University, College Station, Texas.